LADONE MARY KAY sold 9.4% of their position (3.91K shares) of KESTRA MEDICAL TECHNOLOGIES, LTD. on the open market
Open‑market sale worth $98.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2026ACC: 0001193125-26-388297
Director
Since Mar 2025
+3.31K
Net shares
Net buyer
$98.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
7.22K acquired · 3.91K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−3.91K
Price / share
$25.20
Trade value
$98.46K
% of position
9.4%
9/8/2026
41.41K→37.51K
Common Shares
Direct
Shares
+7.22K
Price / share
—
Trade value
—
% of position
19.2%
9/9/2026
37.51K→44.72K
Total
Net shares
+3.31K
Net value
-$98.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/8/2026 | S · Sale | −3.91K | $25.20 | $98.46K | 9.4% | 41.41K | 37.51K |
| Common Shares Direct | 9/9/2026 | A · Award | +7.22K | — | — | 19.2% | 37.51K | 44.72K |
| Total | +3.31K | -$98.46K | ||||||
Derivative Transactions0
No derivative transactions reported